Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-01

FDA Approved: BRIMONIDINE TARTRATE — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved brimonidine tartrate for an original application (ANDA) from Alembic Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIMONIDINE TARTRATE (brimonidine tartrate)

Snippet

ORIG AP for BRIMONIDINE TARTRATE (BRIMONIDINE TARTRATE)